Clinical Trials Browser

Phase NA × Leukemia, Prolymphocytic × Alemtuzumab × Clear all

NCT00021151 2014-01-09

Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia

Phase NA Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic